India to Jordan: Tacrolimus Export Trade Route
India has recorded 5 verified shipments of Tacrolimus exported to Jordan, representing a combined trade value of $4.3M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $863.7K USD. The leading Indian exporter is PANACEA BIOTEC PHARMA LIMITED, which accounts for 99% of total export value with 3 shipments worth $4.3M USD. On the buying side, AL-SALIM DRUG STORE is the largest importer in Jordan with $4.2M USD in purchases. The top 3 suppliers — PANACEA BIOTEC PHARMA LIMITED, SCOTT EDIL PHARMACIA LTD, CENTURION HEALTHCARE PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Jordan Tacrolimus corridor is one of India's established pharmaceutical export routes, with 5 shipments documented worth a combined $4.3M USD. The route is dominated by PANACEA BIOTEC PHARMA LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's tacrolimus manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $863.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 21.0%, placing it at rank #11 among India's top tacrolimus export destinations globally.
On the import side, key buyers of Indian tacrolimus in Jordan include AL-SALIM DRUG STORE, JAWEDA INT'L DRUG STORE, DIRECTOR OF BLUBARCO FOR TRADING and 1 others. AL-SALIM DRUG STORE is the single largest importer with 1 shipments valued at $4.2M USD.
Route Characteristics
- Average transit19 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portMundra
Market Position
- Global rank#11
- Annual growth+21.0%
- Demand growth+19.7%
- Regulatory ease68/100
Top 10 Indian Tacrolimus Exporters to Jordan
Showing top 10 of 3 Indian suppliers exporting Tacrolimus to Jordan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PANACEA BIOTEC PHARMA LIMITED Avg $1.4M per shipment | 3 | $4.3M | 99.4% |
| 2 | SCOTT EDIL PHARMACIA LTD Avg $21.0K per shipment | 1 | $21.0K | 0.5% |
| 3 | CENTURION HEALTHCARE PRIVATE LIMITED Avg $4.1K per shipment | 1 | $4.1K | 0.1% |
This table shows the top 10 of 3 Indian companies exporting tacrolimus to Jordan, ranked by total trade value. The listed exporters are: PANACEA BIOTEC PHARMA LIMITED, SCOTT EDIL PHARMACIA LTD, CENTURION HEALTHCARE PRIVATE LIMITED. PANACEA BIOTEC PHARMA LIMITED is the dominant supplier with 3 shipments worth $4.3M USD, giving it a 99% market share.
Top 10 Tacrolimus Importers in Jordan
Showing top 10 of 4 known buyers in Jordan receiving Tacrolimus shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian tacrolimus in Jordan include AL-SALIM DRUG STORE, JAWEDA INT'L DRUG STORE, DIRECTOR OF BLUBARCO FOR TRADING, TO THE ORDER OF. The largest importer is AL-SALIM DRUG STORE, accounting for $4.2M USD across 1 shipments — representing 98% of all tacrolimus imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AL-SALIM DRUG STORE | 1 | $4.2M | 97.8% |
| 2 | JAWEDA INT'L DRUG STORE | 2 | $70.8K | 1.6% |
| 3 | DIRECTOR OF BLUBARCO FOR TRADING | 1 | $21.0K | 0.5% |
| 4 | TO THE ORDER OF | 1 | $4.1K | 0.1% |
Top 10 Tacrolimus Formulations Imported by Jordan
Showing top 10 of 5 product formulations shipped on the India to Jordan Tacrolimus route, ranked by trade value
Jordan imports a wide range of tacrolimus formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PANGRAF 1.0 MG CAPSULES (EACH HARD GELATIN CAPSULE CONTAINS TACROLIMUS EQUIVALENT TO ANHYDROUS TACROLIMUS 1.0 MG) B/N.30 — accounts for $4.2M USD across 1 shipments. A total of 5 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PANGRAF 1.0 MG CAPSULES (EACH HARD GELATIN CAPSULE CONTAINS TACROLIMUS EQUIVALENT TO ANHYDROUS TACROLIMUS 1.0 MG) B/N.30 | 1 | $4.2M | 97.8% |
| 2 | PANGRAF 1.0 MG CAPSULES (EACH HARD GELATIN CAPSULE CONTAINS TACROLIMUS EQUIVALENT TO ANHYDROUS TACROLIMUS 1.0 MG) (TOTAL | 1 | $60.1K | 1.4% |
| 3 | HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION TACROLIMUS OINTMENT 0.1%W/W BT:XE3E10 MANUFACTURING :05/2023.EXP:04/2026 | 1 | $21.0K | 0.5% |
| 4 | PANGRAF 1.0 MG CAPSULES (EACH HARD GELATIN CAPSULE CONTAINS TACROLIMUS EQUIVALENT TO ANHYDROUS TACROLIMUS 1.0 MG TOTAL 4 | 1 | $10.7K | 0.2% |
| 5 | HARMLESS MEDICINES FOR HUMAN CONSUMPTIONTACROLEN (TACROLIMUS OINTMENT 0.1% W/W)(30 G) | 1 | $4.1K | 0.1% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
Mundra handles the highest volume with 1 shipments. Transit time averages 19 days by sea.
Market Dynamics
India's tacrolimus exports to Jordan are driven primarily by a handful of large-scale manufacturers. PANACEA BIOTEC PHARMA LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Jordan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — PANACEA BIOTEC PHARMA LIMITED, SCOTT EDIL PHARMACIA LTD, CENTURION HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $863.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pangraf 1.0 mg capsules (each hard gelatin capsule contains tacrolimus equivalent to anhydrous tacrolimus 1.0 mg) (total and harmless pharmaceutical medicines finished formulation tacrolimus ointment 0.1%w/w bt:xe3e10 manufacturing :05/2023.exp:04/2026, suggesting that buyers in Jordan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AL-SALIM DRUG STORE is the largest importer with 1 shipments worth $4.2M USD — representing 98% of all tacrolimus imports from India on this route.
Route Statistics
- Trade Volume
- $4.3M
- Avg. Shipment
- $863.7K
- Suppliers
- 3
- Buyers
- 4
- Transit (Sea)
- ~19 days
- Annual Growth
- +21.0%
Related Analysis
Other Tacrolimus Routes
Unlock the Full India to Jordan Tacrolimus Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 5 shipments on this route.
Frequently Asked Questions — India to Jordan Tacrolimus Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Tacrolimus to Jordan?
The leading Indian exporters of Tacrolimus to Jordan are PANACEA BIOTEC PHARMA LIMITED, SCOTT EDIL PHARMACIA LTD, CENTURION HEALTHCARE PRIVATE LIMITED. PANACEA BIOTEC PHARMA LIMITED holds the largest market share at approximately 99% of total trade value on this route.
Q What is the total value of Tacrolimus exports from India to Jordan?
India exports Tacrolimus to Jordan worth approximately $4.3M USD across 5 recorded shipments. The average value per shipment is $863.7K USD.
Q Which ports does India use to ship Tacrolimus to Jordan?
The most active port of origin is Mundra with 1 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Jordan for Tacrolimus?
The average transit time for Tacrolimus shipments from India to Jordan is approximately 19 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Jordan Tacrolimus trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.0% with demand growth tracking at 19.7%. The route is ranked #11 among India's top Tacrolimus export destinations globally.
Q How many suppliers are active on the India to Jordan Tacrolimus route?
There are currently 3 active Indian suppliers exporting Tacrolimus to Jordan. The market is moderately concentrated with PANACEA BIOTEC PHARMA LIMITED accounting for 99% of total shipment value.
Q Who are the main importers of Tacrolimus from India in Jordan?
The leading importers of Indian Tacrolimus in Jordan include AL-SALIM DRUG STORE, JAWEDA INT'L DRUG STORE, DIRECTOR OF BLUBARCO FOR TRADING, TO THE ORDER OF. AL-SALIM DRUG STORE is the largest buyer with 1 shipments worth $4.2M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Jordan export trade corridor identified from Indian Customs (DGFT) records for Tacrolimus.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 4 importers in Jordan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 5 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists